GlobalData on MSN2mon
HMNC completes subject randomisation in Phase IIb MDD treatment trialHMNC Brain Health (HMNC) has completed the subject randomisation in its placebo-controlled Phase IIb OLIVE trial of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback